TipRanks
Advertisement
Advertisement
Precigen options imply 11.1% move in share price post-earnings
PremiumThe FlyPrecigen options imply 11.1% move in share price post-earnings
1M ago
Precigen, Inc. (PGEN) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Precigen, Inc. (PGEN) Q2 Earnings Cheat Sheet
2M ago
Precigen Shareholders Expand Incentive Plan, Reaffirm Governance
Premium
Company Announcements
Precigen Shareholders Expand Incentive Plan, Reaffirm Governance
3M ago
Precigen Earnings Call Highlights PAPZIMEOS Launch Surge
PremiumCompany AnnouncementsPrecigen Earnings Call Highlights PAPZIMEOS Launch Surge
4M ago
Precigen price target raised to $11 from $10 at H.C. Wainwright
Premium
The Fly
Precigen price target raised to $11 from $10 at H.C. Wainwright
4M ago
Precigen price target raised to $11 from $9 at Citizens
Premium
The Fly
Precigen price target raised to $11 from $9 at Citizens
4M ago
Precigen sees Q1 revenue exceeding $18M, consensus $20.8M
PremiumThe FlyPrecigen sees Q1 revenue exceeding $18M, consensus $20.8M
5M ago
Precigen sees ‘robust uptake’ in usage of Papzimeos since its launch
Premium
The Fly
Precigen sees ‘robust uptake’ in usage of Papzimeos since its launch
5M ago
Papzimeos: Accelerating Commercial Ramp, Larger-Than-Expected RRP Market, and Strong 2026 Revenue Outlook Support Buy Rating
Premium
Ratings
Papzimeos: Accelerating Commercial Ramp, Larger-Than-Expected RRP Market, and Strong 2026 Revenue Outlook Support Buy Rating
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100